 Ritsuko Iwanaga
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E2F1 Transcription Factor | 11 | 2024 | 61 | 1.590 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1356 | 0.720 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 18 | 0.690 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 634 | 0.680 |
Why?
| | Melanocytes | 1 | 2020 | 64 | 0.660 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 265 | 0.560 |
Why?
| | Zebrafish | 1 | 2020 | 458 | 0.500 |
Why?
| | Ligaments | 1 | 2016 | 53 | 0.500 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 821 | 0.480 |
Why?
| | E2F Transcription Factors | 6 | 2023 | 59 | 0.480 |
Why?
| | Pelvis | 1 | 2016 | 103 | 0.480 |
Why?
| | Uterus | 1 | 2016 | 206 | 0.470 |
Why?
| | Gene Products, tax | 2 | 2024 | 13 | 0.460 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2024 | 511 | 0.460 |
Why?
| | Human T-lymphotropic virus 1 | 2 | 2024 | 28 | 0.450 |
Why?
| | Models, Animal | 1 | 2016 | 375 | 0.450 |
Why?
| | Vagina | 1 | 2016 | 175 | 0.440 |
Why?
| | Homeodomain Proteins | 3 | 2012 | 494 | 0.430 |
Why?
| | Polycomb Repressive Complex 1 | 2 | 2024 | 47 | 0.430 |
Why?
| | Melanoma | 1 | 2020 | 729 | 0.420 |
Why?
| | Transforming Growth Factor beta | 2 | 2012 | 457 | 0.390 |
Why?
| | Gene Expression Regulation | 6 | 2023 | 2548 | 0.380 |
Why?
| | Ovarian Neoplasms | 3 | 2024 | 487 | 0.380 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 169 | 0.370 |
Why?
| | Promoter Regions, Genetic | 11 | 2024 | 1207 | 0.370 |
Why?
| | Cell Line, Tumor | 11 | 2024 | 3215 | 0.360 |
Why?
| | Neoplastic Stem Cells | 3 | 2014 | 380 | 0.330 |
Why?
| | Transcriptional Activation | 4 | 2024 | 366 | 0.320 |
Why?
| | Breast Neoplasms | 3 | 2014 | 2142 | 0.250 |
Why?
| | Genes, Tumor Suppressor | 4 | 2023 | 86 | 0.250 |
Why?
| | Growth Substances | 1 | 2004 | 152 | 0.230 |
Why?
| | Cyclin-Dependent Kinases | 2 | 2024 | 130 | 0.220 |
Why?
| | BRCA2 Protein | 1 | 2024 | 53 | 0.220 |
Why?
| | DEAD-box RNA Helicases | 1 | 2024 | 65 | 0.220 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 28 | 0.220 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2024 | 68 | 0.210 |
Why?
| | Fibroblasts | 5 | 2018 | 948 | 0.210 |
Why?
| | DNA Repair | 1 | 2004 | 207 | 0.210 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 125 | 0.200 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.200 |
Why?
| | Tumor Suppressor Proteins | 2 | 2014 | 317 | 0.180 |
Why?
| | Tumor Suppressor Protein p14ARF | 2 | 2014 | 7 | 0.180 |
Why?
| | Animals | 9 | 2024 | 35346 | 0.170 |
Why?
| | Signal Transduction | 3 | 2016 | 4924 | 0.170 |
Why?
| | Mice | 6 | 2024 | 16935 | 0.170 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 13 | 0.170 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.170 |
Why?
| | Prognosis | 3 | 2020 | 3791 | 0.160 |
Why?
| | Neoplasms | 3 | 2023 | 2469 | 0.160 |
Why?
| | Apoptosis | 8 | 2024 | 2503 | 0.160 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 857 | 0.150 |
Why?
| | Humans | 23 | 2024 | 129378 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 2 | 2015 | 637 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 19 | 0.140 |
Why?
| | Macrophages | 1 | 2024 | 1480 | 0.130 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 586 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 117 | 0.130 |
Why?
| | Connective Tissue | 1 | 2016 | 38 | 0.130 |
Why?
| | Survival Rate | 1 | 2020 | 1874 | 0.120 |
Why?
| | Pelvic Organ Prolapse | 1 | 2016 | 45 | 0.120 |
Why?
| | DNA-Binding Proteins | 4 | 2018 | 1443 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2016 | 157 | 0.120 |
Why?
| | Disease Progression | 2 | 2020 | 2626 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2014 | 17 | 0.120 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 40 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 359 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 182 | 0.110 |
Why?
| | Nuclear Proteins | 2 | 2012 | 663 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 171 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2020 | 1901 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2020 | 4082 | 0.100 |
Why?
| | Superoxide Dismutase | 1 | 2014 | 342 | 0.100 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 35 | 0.100 |
Why?
| | Heterografts | 1 | 2012 | 131 | 0.100 |
Why?
| | Cell Line | 4 | 2018 | 2780 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2012 | 482 | 0.090 |
Why?
| | Female | 7 | 2024 | 68686 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2406 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2015 | 1119 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 73 | 0.080 |
Why?
| | Response Elements | 2 | 2008 | 90 | 0.080 |
Why?
| | Protein Binding | 4 | 2024 | 2121 | 0.080 |
Why?
| | Rats | 1 | 2016 | 5497 | 0.070 |
Why?
| | Retinoblastoma Protein | 3 | 2016 | 54 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 69 | 0.070 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 5438 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1706 | 0.060 |
Why?
| | MutS Homolog 3 Protein | 1 | 2004 | 2 | 0.060 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2004 | 6 | 0.060 |
Why?
| | MutL Protein Homolog 1 | 1 | 2004 | 12 | 0.060 |
Why?
| | MutS Homolog 2 Protein | 1 | 2004 | 14 | 0.060 |
Why?
| | Culture Media, Serum-Free | 1 | 2004 | 49 | 0.060 |
Why?
| | Rad51 Recombinase | 1 | 2004 | 13 | 0.060 |
Why?
| | DNA Repair Enzymes | 1 | 2004 | 21 | 0.060 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 39 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2024 | 134 | 0.060 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 107 | 0.060 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 82 | 0.060 |
Why?
| | Base Sequence | 2 | 2005 | 2142 | 0.060 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2024 | 90 | 0.050 |
Why?
| | Transcription Factors | 2 | 2018 | 1650 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2005 | 287 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2005 | 436 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2831 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 253 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 354 | 0.050 |
Why?
| | DNA Replication | 1 | 2004 | 228 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 796 | 0.050 |
Why?
| | Telomerase | 1 | 2005 | 233 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4061 | 0.050 |
Why?
| | Neoplasm Transplantation | 2 | 2014 | 257 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 399 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2344 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 424 | 0.050 |
Why?
| | Lysine | 1 | 2023 | 286 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2004 | 743 | 0.040 |
Why?
| | Serum | 2 | 2012 | 57 | 0.040 |
Why?
| | Transplantation, Heterologous | 2 | 2012 | 192 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2024 | 2391 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 653 | 0.040 |
Why?
| | Mice, SCID | 2 | 2012 | 351 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1713 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 758 | 0.040 |
Why?
| | Adenovirus E1A Proteins | 2 | 2012 | 11 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 613 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1418 | 0.040 |
Why?
| | Histones | 1 | 2024 | 588 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Dimerization | 1 | 2018 | 192 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 925 | 0.040 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 4 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2005 | 1928 | 0.030 |
Why?
| | RNA Interference | 1 | 2018 | 448 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 587 | 0.030 |
Why?
| | Claudins | 1 | 2014 | 25 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2014 | 101 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 315 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2014 | 647 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2012 | 14 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2014 | 292 | 0.020 |
Why?
| | Etoposide | 1 | 2012 | 148 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 162 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2012 | 184 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 596 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1245 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 192 | 0.020 |
Why?
| | Point Mutation | 1 | 2012 | 225 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2012 | 361 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2012 | 2707 | 0.020 |
Why?
| | Antioxidants | 1 | 2014 | 559 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 911 | 0.020 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2009 | 66 | 0.020 |
Why?
| | E2F4 Transcription Factor | 1 | 2008 | 8 | 0.020 |
Why?
| | Mesoderm | 1 | 2009 | 137 | 0.020 |
Why?
| | Epithelium | 1 | 2009 | 311 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1156 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1269 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 588 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1698 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 610 | 0.020 |
Why?
| | Cyclin D | 1 | 2005 | 8 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2005 | 63 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 83 | 0.020 |
Why?
| | Cyclins | 1 | 2005 | 89 | 0.020 |
Why?
| | Gene Silencing | 1 | 2005 | 190 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1471 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2119 | 0.010 |
Why?
| | Cell Cycle | 1 | 2005 | 592 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1252 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 839 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1719 | 0.010 |
Why?
| | Mutation | 1 | 2005 | 3717 | 0.010 |
Why?
| | Male | 1 | 2009 | 63595 | 0.000 |
Why?
|
|
Iwanaga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|